ADVISORY/Experts Available to Discuss Need for Improved Prostate Cancer Screening.

Business Editors

ADVISORY...

--(BUSINESS WIRE)

TOPIC: A study published in Thursday's New England Journal of Medicine shows that some men who have "normal" results from the prostate-specific antigen test (PSA) may still have prostate cancer, according to an article by USATODAY.com. PSA scores above 4 can indicate cancer. The study of 3,000 men found cancer in 15 percent of the men who had PSA scores below 4. Researchers suggest that a better screening method be developed to identify prostate cancer.

EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:

Dr. Marc B. Garnick is an internationally renowned expert on urologic cancer. He has dedicated his career to the development of new drug therapies and maintains a practice at the Beth Israel Deaconess Medical Center and is Clinical Professor of Medicine at Harvard Medical School. At PRAECIS, he directs the clinical development of abarelix depot (Plenaxis), which was approved by the FDA in November 2003 for the treatment of late-stage symptomatic prostate cancer. Dr. Garnick received his medical degree from the University of Pennsylvania School of Medicine and completed his internship and residency at the university's hospital. He has also completed a research and clinical fellowship in oncology with the National Institutes of Health (NIH) and Harvard Medical School. He is a member of numerous professional organizations, as well as several editorial boards for peer-reviewed publications. Dr. Garnick serves on numerous United States government sponsored committees on prostate cancer, including the Prostate Cancer Working Group, and the Scientific Advisory Board on Cancer Prevention and the SPORE Grant Funding Mechanism for Prostate Cancer, both of the National Cancer Institutes. He also serves as the co-director of the International Conference on Neoadjuvant Hormone Therapy for Prostate Cancer and is a member of the National Prostate Cancer Coalition's (NPCC) Advisory Council. Dr. Garnick has authored more than 300 written works, including books, peer reviewed articles and letters. Most recently, he co-authored an article entitled "Combating Prostate Cancer" which appeared in the December 1998 issue of Scientific American. He has written a book titled A Patient's Guide to Prostate Cancer. 617-443-9933 x329 [e-mail]

Dr. Rodney Anderson, of Stanford University, School of Medicine was engaged in basic laboratory research for one year as a National Institutes of Health research fellow under the direction of William R. Fair, MD. Upon finishing his residency, he was awarded the American Urologic Association Wyland Leadbetter Research Scholarship and studied prostatitis with Dr. Thomas A. Stamey, the Chairman of Urology at Stanford. 650-723-3391

Dr. Ronald Citron is an independent consultant who can share his expertise on causation analysis of missed cancer diagnosis. 707-942-5818

ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.

ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/.